满贯集团(03390.HK)附属斥2,000万元认购雅各臣关连品牌保健护理业务股份
满贯集团(03390.HK)公布,间接全资附属景柏同意以现金2,000万元认购目标公司JBM(Healthcare)的配发股份。目标集团主要从事品牌保健护理业务,包括品牌药、品牌中药以及品牌健康及保健产品(如保健品、个人护理产品以及健康诊断套件)。
目标公司为目标控股公司JBM Group (BVI)的全资附属。目标控股公司为雅各臣(02633.HK)的全资附属。目前,目标控股公司的同系附属持有公司已发行股份约7.07%,及集团与目标控股公司的若干同系附属进行各类业务合作,包括作为集团供应商及共同投资於并非集团成员公司的公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.